YolTech to Present at BIO-Europe 2025

YolTech Therapeutics will participate in BIO-Europe 2025, taking place in Vienna, Austria. The annual conference brings together global leaders across biotechnology and pharmaceutical sectors, fostering collaboration and innovation in drug discovery and development. Dr. Alexandre Moreau, Global Strategic Advisor of YolTech Therapeutics, will deliver a company presentation during the event.

Dr. Moreau will discuss YolTech’s continued progress in developing transformative in vivo gene-editing therapies and an expanding clinical portfolio, highlighting the company’s vision for global growth and strategic partnerships.

Date: Monday, November 3, 2025

Time: 13:45–14:00 (CET)

Venue: Vienna Congress and Convention Center, Presenting Company Theater 1

Last

YolTech Therapeutics Receives FDA IND Clearance to Initiate Global Pivotal Trial of In Vivo Gene-Editing Therapy YOLT-203 for Primary Hyperoxaluria Type 1 (PH1)
Next

YolTech Therapeutics Raises $45 Million in Series B Financing Led by AstraZeneca-CICC

LATESTNEWS

YolTech Presented Proof-of-Concept Data from Clinical Trial of YOLT-202 in PiZZ Alpha-1 Antitrypsin Deficiency (AATD) Patients at European Respiratory Society Congress 2026

Sep 07, 2026
YolTech to Present Late-Breaking Proof-of-Concept Clinical Data from YOLT-202 Clinical Trial in PiZZ Alpha-1 Antitrypsin Deficiency (AATD) Patients at European Respiratory Society Congress 2026

Sep 05, 2026
YolTech to Present Positive Data from Clinical Trial of YOLT-201 in ATTR-CM Patients at European Society of Cardiology Congress 2026

Aug 27, 2026